Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 26 (4), 724-730, 2015-04
Elsevier BV